Holen Sie sich die Stockscreener-App
335.31
4.38%
-15.36
Handel nachbörslich:
335.31
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$350.67
Offen:
$352.14
24-Stunden-Volumen:
3.39M
Relative Volume:
2.24
Marktkapitalisierung:
$65.05B
Einnahmen:
$321.33B
Nettoeinkommen (Verlust:
$1.57B
KGV:
42.17
EPS:
7.9518
Netto-Cashflow:
$3.21B
1W Leistung:
-9.01%
1M Leistung:
-1.65%
6M Leistung:
+15.01%
1J Leistung:
+34.10%
1-Tages-Spanne:
$333.39
$352.14
1-Wochen-Bereich:
$333.39
$370.50
52-Wochen-Spanne:
$223.92
$377.54
Cencora Inc Stock (COR) Company Profile
Firmenname
Cencora Inc
Sektor
Branche
Telefon
610-727-7000
Adresse
1 WEST FIRST AVENUE, CONSHOHOCKEN
Vergleichen Sie COR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
335.31 | 68.03B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
MCK
Mckesson Corporation
|
805.37 | 102.41B | 387.09B | 4.23B | 6.01B | 32.12 |
|
CAH
Cardinal Health Inc
|
199.71 | 48.74B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
HSIC
Henry Schein Inc
|
72.88 | 8.44B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.39 | 790.85M | 2.22M | -5.63M | -1.68M | -0.24 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | Fortgesetzt | Mizuho | Outperform |
| 2024-09-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-03-31 | Eingeleitet | Citigroup | Buy |
| 2023-01-31 | Fortgesetzt | Evercore ISI | Outperform |
| 2022-10-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-07-11 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-06-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-05-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-04-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-12 | Fortgesetzt | Evercore ISI | In-line |
| 2021-02-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-02-02 | Hochstufung | Cowen | Market Perform → Outperform |
| 2021-01-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2021-01-06 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | Eingeleitet | Mizuho | Neutral |
| 2020-08-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | Eingeleitet | Barclays | Underweight |
| 2020-06-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-04-16 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-03-17 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-02-11 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-07-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | Eingeleitet | Guggenheim | Buy |
| 2019-04-10 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-02-11 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-10 | Herabstufung | Jefferies | Buy → Hold |
| 2018-10-26 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | Eingeleitet | Berenberg | Buy |
| 2018-07-17 | Fortgesetzt | Stifel | Hold |
| 2018-04-09 | Eingeleitet | MoffettNathanson | Buy |
| 2018-03-12 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | Eingeleitet | JP Morgan | Neutral |
| 2017-09-22 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Cencora Inc Aktie (COR) Neueste Nachrichten
Cencora Is Buying Big—But Can Its Acquisition Spree Deliver Massive Long-Term Growth? - Smartkarma
How Is Cencora’s Stock Performance Compared to Other Medical Stocks? - MSN
Why Cencora (COR) Shares Are Trading Lower Today - Finviz
JPMorgan raises Cencora (COR) price target after financial model update - MSN
JPMorgan Raises Cencora (COR) Price Target After Financial Model Update - Insider Monkey
15 Dividend Stocks That Outperform the S&P 500 - Insider Monkey
Cencora Enhances Global Pharmaceutical Logistics Services, Cold Chain Capabilities - Markets Financial Content
Why Cencora Inc. stock could be top winnerTrade Analysis Report & Growth Oriented Trade Recommendations - Newser
Can Cencora Inc. (ABG) stock surprise with quarterly resultsQuarterly Portfolio Summary & Daily Entry Point Alerts - Newser
Why Cencora Inc. stock is in analyst buy zone2025 Trading Volume Trends & Expert Approved Momentum Trade Ideas - Newser
How Cencora Inc. (ABG) stock trades after rate cutsQuarterly Profit Review & Technical Pattern Based Signals - Newser
Is Cencora Inc. stock supported by strong cash flowsWeekly Trading Summary & Safe Entry Momentum Stock Tips - Newser
Is Cencora Inc. (ABG) stock supported by strong fundamentalsEarnings Overview Summary & Free High Return Stock Watch Alerts - Newser
Can Cencora Inc. stock surprise markets with earningsQuarterly Portfolio Summary & AI Enhanced Execution Alerts - Newser
Why Cencora Inc. (ABG) stock stays on top picks2025 Trading Volume Trends & AI Driven Stock Price Forecasts - Newser
Why Cencora Inc. stock could break out in 2025Portfolio Update Report & AI Enhanced Execution Alerts - Newser
Cencora (COR) Upgraded to Buy: Here's Why - sharewise.com
Is Cencora Inc. (ABG) stock a buy during volatile marketsPortfolio Return Summary & Long-Term Capital Growth Ideas - Newser
How Cencora Inc. stock compares with market leadersMarket Movers & Advanced Swing Trade Entry Plans - Newser
Is Cencora Inc. stock oversold or undervaluedPortfolio Update Summary & Free Risk Controlled Daily Trade Plans - Newser
Why Cencora Inc. (ABG) stock stays undervaluedMarket Performance Report & Verified Short-Term Trading Plans - Newser
Is Cencora Inc. (ABG) stock a top hedge fund pickPortfolio Profit Report & High Win Rate Trade Alerts - Newser
Can Cencora Inc. stock sustain free cash flow growth2025 Bull vs Bear & Risk Controlled Stock Pick Alerts - Newser
Will Cencora Inc. (ABG) stock attract long term capital inflowsRisk Management & Real-Time Buy Signal Alerts - Newser
Cencora Stock: Is Wall Street Bullish or Bearish? - MSN
Bearish Setup: What dividend safety score for Cencora Inc. stockPortfolio Performance Summary & Growth Focused Stock Pick Reports - moha.gov.vn
Cencora price target raised to $400 from $340 at Evercore ISI - MSN
Argus Adjusts Price Target on Cencora to $400 From $340, Maintains Buy Rating - MarketScreener
If You Invested $100 In Cencora Stock 5 Years Ago, You Would Have This Much Today - Sahm
How Investors Are Reacting To Cencora (COR) Expanding Global Reach With Alliance Healthcare Acquisition - Yahoo Finance
Will Cencora Inc. (ABG) stock sustain uptrend momentumJuly 2025 Chart Watch & Verified Stock Trade Ideas - BỘ NỘI VỤ
Should You Take Another Look at Cencora After a 64% Rally in 2025? - Yahoo Finance
Market Trends: Is Cencora Inc. stock a safe haven asset2025 Big Picture & Verified Trade Idea Suggestions - BỘ NỘI VỤ
Market Participants Recognise Cencora, Inc.'s (NYSE:COR) Earnings - 富途牛牛
Cencora Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Cencora, Inc. (COR) Stock Forecasts - Yahoo Finance
Cencora, Inc. Faces Business Risks from Unpredictable Global Events - TipRanks
Decoding Cencora Inc (COR): A Strategic SWOT Insight - GuruFocus
Key facts: Cencora, Inc. reports $27.4B revenue rise; executives buy shares - TradingView
Cencora, Inc. SEC 10-K Report - TradingView
Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run? - sharewise.com
[Form 4] Cencora, Inc. Insider Trading Activity - Stock Titan
VP Krikorian Acquires 602 Of Cencora Inc [COR] - TradingView
Cencora Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
How a Fourth Quarter Earnings Beat At Cencora (COR) Has Changed Its Investment Story - simplywall.st
Cencora (COR): Is There Further Upside After Recent Share Price Gains? A Fresh Look at Valuation - simplywall.st
Cencora Inc. (COR) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Cencora Inc stock hits all-time high at 369.04 USD By Investing.com - Investing.com Nigeria
Cencora Inc stock hits all-time high at 369.04 USD - Investing.com
Are Medical Stocks Lagging Cencora, Inc. (COR) This Year? - sharewise.com
Will Cencora Inc. stock sustain bullish trend into 2025Quarterly Profit Review & Real-Time Buy Signal Alerts - newser.com
Finanzdaten der Cencora Inc-Aktie (COR)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.64%
1.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):